Clinical orthopaedics and related research
-
Clin. Orthop. Relat. Res. · Jul 2010
Randomized Controlled TrialMedial knee osteoarthritis treated by insoles or braces: a randomized trial.
There is controversial evidence regarding whether foot orthoses or knee braces improve pain and function or correct malalignment in selected patients with osteoarthritis (OA) of the medial knee compartment. However, insoles are safe and less costly than knee bracing if they relieve pain or improve function. ⋯ Level I, therapeutic study. See the Guidelines for Authors for a complete description of level of evidence.
-
Pelvic fractures represent major injury. Women of childbearing age who have sustained pelvic fractures question whether they can have children and what type of delivery will be possible. ⋯ Level III, therapeutic study. See the Guidelines for Authors for a complete description of levels of evidence.
-
Clin. Orthop. Relat. Res. · Jul 2010
Comparative StudyDoes ultrasound correlate with surgical or histologic findings in greater trochanteric pain syndrome? A pilot study.
Greater trochanteric pain syndrome can be severely debilitating. Ideal imaging modalities are not established, treatments are not reliably evaluated, and the underlying pathology is not well understood. ⋯ Level IV, case series. See the Guidelines for Authors for a complete description of levels of evidence.
-
Clin. Orthop. Relat. Res. · Jul 2010
Comparative StudyComparison of 5766 vertebral compression fractures treated with or without kyphoplasty.
The majority of the 700,000 osteoporotic vertebral compression fractures (VCFs) that occur annually in the United States affect women. The total treatment costs exceed $17 billion and approximate the total costs of breast cancer ($13 billion) and heart disease ($19 billion). Balloon-assisted percutaneous vertebral augmentation with bone cement (kyphoplasty) reportedly reduces VCF-related pain and accelerates return of independent functional mobility. Kyphoplasty may decrease overall cost of VCF treatment costs by reducing use of posttreatment medical resources. ⋯ Level III, therapeutic study. See Guidelines for Authors for a complete description of levels of evidence.
-
Clin. Orthop. Relat. Res. · Jul 2010
One intraoperative dose of tranexamic Acid for patients having primary hip or knee arthroplasty.
Multiple studies suggest tranexamic acid reduces blood loss and red cell transfusions in patients undergoing THA or TKA. However, many of the dosing schedules in these studies are not ideally suited for routine application. ⋯ Level III, therapeutic study. See Guidelines for Authors for a complete description of levels of evidence.